RECALL OF HEPATITIS B DRUG BY CIPLA QUALITY CHEMICAL INDUSTRIES LTD
Cipla Quality Chemical Industries Limited Bell Ringing and First Day of Trading on the Uganda Securities Exchange
September 19, 2018
Shareholders guided tour of the CiplaQcil manufacturing plant
October 18, 2019

PRESS STATEMENT: RECALL OF HEPATITIS B DRUG BY CIPLA QUALITY CHEMICAL INDUSTRIES LTD

Referenceis made to several media reports that have been circulating in regard to the recall of Texavir, a Tenofovir baseddrug for the managementof hepatitis B manufactured by Cipla Quality Chemical Industries Ltd (CiplaQCIL). View full statement